• Thurs news: Sage R&D layoffs. Another Sanofi radiopharma deal. Novartis loses bid to block generic. Kezar lupus trial stopped. Why are so many pharmacies closing. See more on our front page

Compensation??









This is honestly one of the cheapest companies out there, with the most unqualified leadership (JG is absolutely clueless) and most out-of-touch goals imaginable. Also, the accidentally overpaid some of the reps on quote and now those reps have to pay that money back.
 
















The folks running this company are in over their heads. They never should’ve merged cbr and dbu sales forces. Both sides used to be successful. Now neither are. So sad.